☆ 4.3 Review

Transdifferentiation, phenotypic infidelity, progression, and transformation in T/NK-cell neoplasms: Report from the 2021 SH/EAHP Workshop

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Hematology

Genetic and epigenetic insights into cutaneous T-cell lymphoma

Cornelis P. Tensen et al.

Summary: Significant progress has been made in understanding the pathogenesis of CTCLs in recent years, thanks to advancements in CTCL classifications and technical innovations. These studies have revealed extensive heterogeneity between different CTCL subtypes and identified recurrent alterations that are highly characteristic for specific diagnostic subgroups. These findings have potential implications for the development of targeted therapeutic strategies.

BLOOD (2022)

Add to Collection

Article Hematology

Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis

Rachel Dobson et al.

Summary: This study found that the RHOA Gly17Val mutation can effectively detect AITL and PTCL-TFH at an early stage, and this mutation was detected in preceding or follow-up biopsies, even in the absence of evidence of lymphoma in histological, immunophenotypic, and clonality analysis.

HAEMATOLOGICA (2022)

Add to Collection

Review Cell Biology

CD20+ T cells: an emerging T cell subset in human pathology

Adrian Y. S. Lee

Summary: Although CD20 is primarily known as a B cell marker, it has been observed in a subset of T cells as well. These CD20(+)T cells appear to express more inflammatory cytokines and markers of effector function compared to CD20(-)T cells. The current understanding is that CD20 may be acquired from B cells through trogocytosis. CD20(+)T cells can be found in various diseases including autoimmune diseases, malignancies, and HIV infections. Multiple sclerosis is one of the best-studied diseases where CD20(+)T cells are found and therapeutic interventions targeting CD20 have shown promise in depleting these cells.

INFLAMMATION RESEARCH (2022)

Add to Collection

Article Pathology

The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy

Caoimhe Egan et al.

Summary: Histiocytic sarcoma and tumors with dendritic cell differentiation often exhibit mutations in the RAS/MAPK pathway, suggesting a clonal relationship with associated lymphoid malignancies. Particularly, sHDT associated with follicular lymphoma commonly shares a similar mutational profile with the associated malignancy, with frequent mutations in CREBBP and KMT2D genes.

MODERN PATHOLOGY (2021)

Add to Collection

Article Biology

Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking

Shuhua Cheng et al.

Summary: This study revealed that clonal hematopoiesis (CH)-associated genomic alterations were shared among CH and T-cell lymphoma in the majority of AITL/PTCL-NOS patients. The presence of CH harboring specific TET2 variants was found to confer a higher risk for concomitant hematologic neoplasms (CHN) in AITL patients. Additionally, aberrant AID/APOBEC activity and tobacco smoking were identified as potential risk factors for AITL/PTCL-NOS progression.

ELIFE (2021)

Add to Collection

Article Dermatology

Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China

Xinhua Wang et al.

Summary: HV-LPD is a rare cutaneous disease associated with Epstein-Barr virus infection, characterized by recurrent papulovesicular and necrotic eruptions. Allogeneic hematopoietic stem cell transplantation may be the preferred choice for relapse and refractory patients with HV-LPD. Adult-onset and high serum EBV DNA loads may indicate an increased risk of aggressive disease in patients with HV-LPD.

JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Article Oncology

Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma

Lucas R. Massoth et al.

Summary: This study conducted comprehensive genomic profiling on 102 patient cases of malignant histiocytic and dendritic cell neoplasms, revealing that MAPK pathway mutations were more common in the malignant histiocytosis group and absent in FDCSs, while NF-kappa B pathway mutations were frequent in FDCSs but rare in the M group histiocytosis. A total of 42 patient tumors (41%) harbored pathogenic mutations that were potentially targetable by approved and/or investigative therapies.

ONCOLOGIST (2021)

Add to Collection

Letter Oncology

Mast cell sarcoma transdifferentiated from clonally-related T-lymphoblastic leukemia upon acquisition of TP53 mutation and genetic complexity

Juehua Gao et al.

LEUKEMIA & LYMPHOMA (2021)

Add to Collection

Review Pathology

Cardiovascular Disease, Aging, and Clonal Hematopoiesis

Megan A. Evans et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 15, 2020 (2020)

Add to Collection

Article Oncology

Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients

Matthias Bleeke et al.

PEDIATRIC BLOOD & CANCER (2020)

Add to Collection

Editorial Material Hematology

Double-hit of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative

Kennosuke Karube et al.

BLOOD (2020)

Add to Collection

Letter Oncology

Secondary histiocytic sarcoma with BRAFV600E mutation after T-cell acute lymphoblastic leukemia in a very young child with dramatic response to dabrafenib and trametinib

Vinayak Venkataraman et al.

PEDIATRIC BLOOD & CANCER (2020)

Add to Collection

Article Hematology

Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms

Natasha E. Lewis et al.

BLOOD ADVANCES (2020)

Add to Collection

Review Multidisciplinary Sciences

Clonal hematopoiesis in human aging and disease

Siddhartha Jaiswal et al.

SCIENCE (2019)

Add to Collection

Editorial Material Hematology

T-cell large granular lymphocyte leukemia transfomation into aggressive T-cell lymphoma: a report of two cases with molecular characterization

Maya Belhadj et al.

HAEMATOLOGICA (2019)

Add to Collection

Editorial Material Hematology

An anaplastic T-cell lymphoma mimicking classical Hodgkin lymphoma

Huan-You Wang et al.

BLOOD (2018)

Add to Collection

Letter Medicine, General & Internal

High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML

Enrico Tiacci et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Pathology

PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature

Indu Arun et al.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2017)

Add to Collection

Article Pathology

Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping

Xueju Wang et al.

HUMAN PATHOLOGY (2017)

Add to Collection

Letter Hematology

Genomic analysis of clonal origin of Langerhans cell histiocytosis following acute lymphoblastic leukaemia

Motohiro Kato et al.

BRITISH JOURNAL OF HAEMATOLOGY (2016)

Add to Collection

Letter Oncology

Independent development of lymphoid and histiocytic malignancies from a shared early precursor

E. Waanders et al.

LEUKEMIA (2016)

Add to Collection

Article Dermatology

CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas

M. Wobser et al.

BRITISH JOURNAL OF DERMATOLOGY (2015)

Add to Collection

Letter Dermatology

Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease

A. R. Nicolae-Cristea et al.

BRITISH JOURNAL OF DERMATOLOGY (2015)

Add to Collection

Article Oncology

Unique clonal relationship between T-cell acute lymphoblastic leukemia and subsequent Langerhans cell histiocytosis with TCR rearrangement and NOTCH1 mutation

Yuichi Yokokawa et al.

GENES CHROMOSOMES & CANCER (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Age-related mutations associated with clonal hematopoietic expansion and malignancies

Mingchao Xie et al.

NATURE MEDICINE (2014)

Add to Collection

Article Medicine, General & Internal

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Giulio Genovese et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Medicine, General & Internal

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Cell Biology

Unique Composite Hematolymphoid Tumor Consisting of a Pro-T Lymphoblastic Lymphoma and an Indeterminate Dendritic Cell Tumor: Evidence for Divergent Common Progenitor Cell Differentiation

Lorenz Buser et al.

PATHOBIOLOGY (2014)

Add to Collection

Article Genetics & Heredity

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

Lambert Busque et al.

NATURE GENETICS (2012)

Add to Collection

Article Oncology

Peripheral T-Cell Lymphoma With Aberrant Expression of CD30, CD15, and CD20

Joo Y. Song et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Add to Collection

Article Pathology

Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies

David A. Wada et al.

MODERN PATHOLOGY (2011)

Add to Collection

Article Pathology

PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus

Andrew L. Feldman et al.

MODERN PATHOLOGY (2010)

Add to Collection

Review Pathology

Clinicopathologic Features of Histiocytic Lesions Following ALL, with a Review of the Literature

Eumenia C. C. Castro et al.

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2010)

Add to Collection

Article Hematology

Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells

Harlan S. Robins et al.

BLOOD (2009)

Add to Collection

Article Dermatology

Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders

M. F. Benner et al.

BRITISH JOURNAL OF DERMATOLOGY (2009)

Add to Collection

Article Biochemistry & Molecular Biology

Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing

J. Douglas Freeman et al.

GENOME RESEARCH (2009)

Add to Collection

Article Pathology

The expression of myeloid antigens CD13 and/or CD33 is a marker of ALK plus anaplastic large cell lymphomas

Ian M. Bovio et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)

Add to Collection

Article Hematology

Aggressive Langerhans cell histiocytosis following T-ALL: Clonally related neoplasms with persistent expression of constitutively active NOTCH1

Scott J. Rodig et al.

AMERICAN JOURNAL OF HEMATOLOGY (2008)

Add to Collection

Article Pathology

CD20+ T-cell Lymphoma Clinicopathologic Analysis of 9 Cases and a Review of the Literature

Aliyah Rahemtullah et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)

Add to Collection

Article Dermatology

CD20 positive mycosis fungoides: a case report

Filiz Sen et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2008)

Add to Collection

Article Oncology

Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis

AL Feldman et al.

LANCET ONCOLOGY (2005)

Add to Collection

Article Hematology

Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma

E Matutes et al.

BRITISH JOURNAL OF HAEMATOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.